Home >> News >> Business >> Psoriasis Treatment Market Is Expected To Reach US$ 12.8 Bn By 2025

Psoriasis Treatment Market Is Expected To Reach US$ 12.8 Bn By 2025

According to the latest market report published by Credence Research, Inc. “Psoriasis Treatment  Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global Psoriasis Treatment  market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of  5.4% from 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Psoriasis Treatment, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/psoriasis-treatment-market

Market Insights

Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation and to stop the skin cells from growing so quickly. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medications. It is observed that, in the base year 2016, interleukin blockers is major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy, furthermore newly approved Siliq (brodalumab) and Tremfya (Guselkumab) expected to drive significant market growth during forecast period. Psoriasis treatment market is categorized on the basis of type such plaque, guttate, flexural or inverse, psoriatic arthritis and others type, however it is observed that plaque psoriasis is major revenue generating segment because it affects more than 70% of psoriasis patients. Psoriasis treatment market is currently dominated by North America, factors such as higher cost of therapy, higher number of psoriasis patient, government reimbursement policies fueling the growth of psoriasis treatment market in North America. However, developing economic condition and rising healthcare awareness would drive the market growth during forecast period.

Market Competition Assessment:

The psoriasis treatment market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as AbbVie Inc., Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Psoriasis Treatment buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Psoriasis Treatment contains:

Analysis and forecast of Psoriasis Treatment market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Psoriasis Treatment market;

Assessment and forecast of Psoriasis Treatment market development;

Financial and business profiles of the leading companies in the Psoriasis Treatment industry.

Scope

– Up to date working Psoriasis Treatment data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Psoriasis Treatment for the period 2018 to 2026

– Planned Psoriasis Treatment additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Psoriasis Treatment projects by region, key countries, and companies

– Details of major planned Psoriasis Treatment projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58469

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *